SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
SPRB
30 hedge funds and large institutions have $4.69M invested in Spruce Biosciences, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+1
Holders Change %
+3.45%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
5
Reduced
10
Closed
4
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$1K
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$420K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$121K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$36.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.8K |
| 5 |
HF
HRT Financial
New York
|
+$15K |
Top Sellers
| 1 |
AC
Almitas Capital
Santa Monica,
California
|
-$188K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$89.1K |
| 3 |
Renaissance Technologies
New York
|
-$85.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36.6K |
| 5 |
SCV
Sands Capital Ventures
Arlington,
Virginia
|
-$29.9K |
